Abstract
Acute posterior multifocal placoid pigment epitheliopathy (APMPPE), serpiginous choroiditis (SPC), relentless placoid chorioretinitis (RPC), and persistent placoid maculopathy (PPM) are grouped together due to the “placoid” nature of their lesions. They historically fall under a broader category of white spot diseases; however, their placoid lesions and time course often distinguish them from other entities. Historically, the pathophysiology of the lesions was not entirely understood, with a controversy of the primary site being the choroid or outer retina. Multimodal imaging has been instrumental in gaining insight to these processes and revealing a primary role of choroidal flow impairment. The role of autoimmunity remains uncertain.
The placoid diseases resemble each other on clinical examination and imaging. Clinically, they are characterized by placoid outer retinal lesions. There is variable development of atrophy that is most severe in SPC as well as choroidal neovascularization, which occurs more commonly in SPC and PPM. There is evidence of choriocapillaris nonperfusion that corresponds with outer retinal changes along with some element of blockage of fluorescence. Optical coherence tomography shows backscatter and hyperreflectivity with loss of transparency of the outer nuclear layer and later development of thinning, loss of photoreceptors, and RPE damage that tends to be more advanced in SPC and PPM.
These entities can be differentiated by their time course, laterality, age distribution, and severity of permanent damage. APMPPE typically presents with a shorter disease course, while RPC confers a much more protracted course. In cases of foveal involvement, outcomes may vary with APMPPE having the most favorable prognosis and SPC carrying the poorest. All seem to respond to immunosuppression.
References
Gass JDM. Acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol. 1968;80:177.
Bonnin P, Lavat P. In connection with a case of Gass placoid epitheliopathy in 1860. Bull Soc Ophthalmol Fr. 1983;83:49.
Gass JDM. Acute posterior multifocal placoid pigment epitheliopathy: a long-term follow-up study. In: Fine SL, editor. Management of retinal vascular and macular disorders. Baltimore: Williams & Wilkins; 1983.
Lewis RA, Martonyi CL. Acute posterior multifocal placoid pigment epitheliopathy: a recurrence. Arch Ophthalmol. 1975;93:235.
Fishman GA, Rabb MF, Kaplan J. Acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol. 1974;92:173.
Kirkman TH, Ffytche TJ, Sanders MD. Placoid pigment epitheliopathy with retinal vasculitis and papillitis. Br J Ophthalmol. 1972;56:875.
Bohlender T, Weindler J, Ratzkova A. Indocyanine green angiography in acute posterior multifocal placoid pigment epitheliopathy. Klin Monatsbl Augenheilkd. 1998;212:170.
Lyness AL, Bird AC. Recurrences of acute posterior multifocal pigment epitheliopathy. Am J Ophthalmol. 1984;98:203.
Damato BE, Nanjiani M, Foulds WS. Acute posterior multifocal placoid pigment epitheliopathy: a follow up study. Trans Ophthalmol Soc UK. 1983;103:517.
Cohen LM, Munk MR, Goldstein DA, et al. Acute posterior multifocal placoid pigment epitheliopathy: a case of 11 recurrences over 15 years. Retina Cases Brief Rep. 2015;9:226–30.
Brezin AP, Massin-Korobelnik P, Boudin M, et al. Acute posterior multifocal placoid pigment epitheliopathy after hepatitis B vaccine. Arch Ophthalmol. 1995;113:297.
Lowder CY, Foster RE, Gordon SM, et al. Acute posterior multifocal placoid pigment epitheliopathy after acute group A streptococcal infection. Am J Ophthalmol. 1996;122:115.
Pagliarini S, Piguet B, Ffytche TJ, et al. Foveal involvement and lack of visual recovery in APMPPE associated with uncommon features. Eye. 1995;9:42.
Vianna R, van Egmond J, Priem H, et al. Natural history and visual outcome in patients with APMPPE. Bull Soc Belg Ophthalmol. 1993;248:73.
Quillen DA, Davis JB, Gottlieb JL, et al. The white dot syndromes. Am J Ophthalmol. 2004;137:538.
Annesley WH, Tomer TL, Sheilds JA. Multifocal placoid pigment epitheliopathy. Am J Ophthalmol. 1973;76:511.
Deutman AF, Lion F. Choriocapillaris nonperfusion in acute multifocal placoid pigment epitheliopathy. Am J Ophthalmol. 1977;84:652.
Schneider U, Inhoffen W, Gelisken F. Indocyanine green angiography in a case of unilateral recurrent posterior acute multifocal placoid pigment epitheliopathy. Acta Ophthalmol Scand. 2003;81:71.
Dhaliwal RS, Maguire AM, Flower RW, et al. Acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiographic study. Retina. 1993;13:317.
Howe LJ, Woon H, Graham EM, et al. Choroidal hypoperfusion in acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiography study. Ophthalmology. 1995;102:790.
Van Liefferinge T, Sallet G, De Laey JJ. Indocyanine green angiography in cases of inflammatory chorioretinopathy. Bull Soc Belg Ophthalmol. 1995;257:73.
Yuzawa M, Kawamura A, Matsui M. Indocyanine green video angiographic findings in acute posterior multifocal placoid pigment epitheliopathy. Acta Ophthalmol. 1994;72:128.
Cimino L, Auer C, Herbort CP. Sensitivity of indocyanine green angiography for the follow-up of active inflammatory choriocapillaropathies. Ocul Immunol Inflamm. 2000;8:275.
Garg S, Jampol LM. Macular serous detachment in acute posterior multifocal placoid pigment epitheliopathy. Retina. 2004;24:650.
Mehta N, Chong J, Tsui E, et al. Presumed foveal bacillary layer detachment in a patient with toxoplasmosis chorioretinitis and pachychoroid disease. Retinal Cases Brief Rep. 2018;00:1–8.
Cicinelli MV, Giuffré C, Marchese A, et al. The bacillary detachment in posterior segment ocular diseases. Ophthalmol Retina. Forthcoming 2020.
Scheufele TA, Witkin AJ, Schocket LS, et al. Photoreceptor atrophy in acute posterior multifocal placoid pigment epitheliopathy demonstrated by optical coherence tomography. Retina. 2005;25:1109.
Lofoco G, Ciucci F, Bardocci A, et al. Optical coherence tomography findings in a case of acute multifocal posterior placoid pigment epitheliopathy (AMPPPE). Eur J Ophthalmol. 2005;15:143.
Cruz-Villegas V, Puliafito CA, Fujimoto JG. Retinal vascular diseases. In: Schuman JS, Puliafito CA, Fujimoto JG, editors. Optical coherence tomography of ocular diseases. Thorofare: Slack Incorporated; 2004.
Invernizzi A, Agarwal A, Cozzi M, et al. Enhanced depth imaging optical coherence tomography features in areas of choriocapillaris hypoperfusion. Retina. 2016;36:2013–21.
Maggio E, Alfano A, Polito A, et al. Choroidal perfusion abnormalities associated with acute posterior multifocal placoid pigment epitheliopathy: a case report. BMC Ophthalmol. 2018;18:87.
Burke TR, Chu CJ, Salvatore S, et al. Application of OCT-angiography to characterise the evolution of chorioretinal lesions in acute posterior multifocal placoid pigment epitheliopathy. Eye (Lond). 2017;31:1399.
Dolz-Marco R, Sarraf D, Giovinazzo V, et al. Optical coherence tomography angiography shows inner choroidal ischemia in acute posterior multifocal placoid pigment epitheliopathy. Retinal Cases Brief Rep. 2017;11:S136–43.
Klufas MA, Phasukkijwatana N, Iafe NA, et al. Optical coherence tomography angiography reveals choriocapillaris flow reduction in placoid chorioretinitis. Ophthalmol Retina. 2017;1:77–91.
Mangeon M, Zett C, Amaral C, et al. Multimodal evaluation of patients with acute posterior multifocal placoid pigment epitheliopathy and serpiginous choroiditis. Ocul Immunol Inflamm. 2018;26:1212–8.
Park SS, Thinda S, Kim DY, et al. Phase-variance optical coherence tomographic angiography imaging of choroidal perfusion changes associated with acute posterior multifocal placoid pigment epitheliopathy. JAMA Ophthalmol. 2016;134:943–5.
Salvatore S, Steeples LR, Ross AH, et al. Multimodal imaging in acute posterior multifocal placoid pigment epitheliopathy demonstrating obstruction of the choriocapillaris. Ophthalmic Surg Lasers Imaging Retina. 2016;47:677–81.
Werner JU, Enders C, Lang GK, et al. Multi-modal imaging including optical coherence tomography angiography in patients with posterior multifocal placoid pigment epitheliopathy. Ophthalmic Surg Lasers Imaging Retina. 2017;48:727–33.
Heiferman MJ, Rahmani S, Jampol LM, et al. Acute posterior multifocal placoid pigment epitheliopathy on optical coherence tomography angiography. Retina. 2017;37:2084–94.
Lee CS, Lee AY, Forooghian F, et al. Fundus autofluorescence features in the inflammatory maculopathies. Clin Ophthalmol. 2014;8:2001.
Spaide RFJR. Autofluorescence imaging of acute posterior multifocal placoid pigment epitheliopathy. Retina. 2006;26:479–82.
Yeh S, Forooghian F, Wong WT, et al. Fundus autofluorescence imaging of the white dot syndromes. Arch Ophthalmol. 2010;128:46–56.
Roberts PK, Nesper PL, Onishi AC, et al. Characterizing photoreceptor changes in acute posterior multifocal placoid pigment epitheliopathy using adaptive optics. Retina. 2018;38:39–48.
Holt WS, Regan CDJ, Trempe C. Acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol. 1976;81:403.
Gass JDM. Inflammatory diseases of the retina and choroid. In: Stereoscopic atlas of macular diseases: diagnosis and treatment. 3rd ed. St. Louis: CV Mosby; 1987.
Isashiki M, Koide H, Yamashita T, et al. Acute posterior multifocal placoid pigment epitheliopathy associated with diffuse retinal vasculitis and late haemorrhagic macular detachment. Br J Ophthalmol. 1986;70:255.
De Souza S, Aslanides IM, Altomare F. Acute posterior multifocal placoid pigment epitheliopathy associated with retinal vasculitis, neovascularization, and subhyaloid hemorrhage. Can J Ophthalmol. 1999;34:343.
Abu El-Asrar AM, Aljazairy AH. Acute posterior multifocal placoid pigment epitheliopathy with retinal vasculitis and papillitis. Eye. 2002;16:642.
Hector RE. Acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol. 1978;86:424.
Allee SD, Marks SJ. Acute posterior multifocal placoid pigment epitheliopathy with bilateral central retinal vein occlusion. Am J Ophthalmol. 1998;126:309.
Jacklin HN. Acute posterior multifocal placoid pigment epitheliopathy and thyroiditis. Arch Ophthalmol. 1977;95:995.
Oh KT, Park DW. Acute posterior multifocal placoid pigment epitheliopathy with corneal stromal infiltrates. Am J Ophthalmol. 1998;125:556.
Bird AC, Hamilton AM. Placoid pigment epitheliopathy presenting with bilateral serous retinal detachments. Br J Ophthalmol. 1972;56:881.
Wright BE, Bird AC, Hamilton AM. Placoid pigment epitheliopathy and Harada’s disease. Br J Ophthalmol. 1978;62:609.
Savino PJ, Weinberg RJ, Yassin JG, et al. Diverse manifestations of acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol. 1974;77:659.
Sigelman J, Behrens M, Hilal S. Acute posterior multifocal placoid pigment epitheliopathy associated with cerebral vasculitis and homonymous hemianopia. Am J Ophthalmol. 1979;88:919.
Bullock JD, Thomas ER, Fletcher RL. Cerebrospinal fluid abnormalities in acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol. 1977;84:45.
Fishman GA, Baskin M, Jednick N. Spinal fluid pleocytosis in acute posterior multifocal placoid pigment epitheliopathy. Ann Ophthalmol. 1977;9:33.
Comu S, Verstraeten T, Rinkoff JS, et al. Neurological manifestations of acute posterior multifocal placoid pigment epitheliopathy. Stroke. 1996;27:996.
Bewermeyer H, Nelles G, Huber M, et al. Pontine infarction in acute posterior multifocal placoid pigment epitheliopathy. J Neurol. 1993;241:22.
Althaus C, Unsold R, Figge C, et al. Cerebral complications in acute posterior multifocal placoid pigment epitheliopathy. Ger J Ophthalmol. 1993;2:150.
Smith CH, Savino PJ, Beck RW, et al. Acute posterior multifocal placoid pigment epitheliopathy and cerebral vasculitis. Arch Neurol. 1983;40:48.
Ryan SJ, Maumenee AE. Acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol. 1972;74:1066.
Jenkins RB, Savino PJ, Pilkerton AR. Placoid pigment epitheliopathy with swelling of the optic discs. Arch Neurol. 1973;29:204.
Clearkin LG, Hung SO. Acute posterior multifocal placoid pigment epitheliopathy associated with transient hearing loss. Trans Ophthalmol Soc UK. 1983;103:562.
El Sanhouri A, Sisk RA, Petersen MRJAO. Mortality from cerebral vasculitis associated with rapid steroid taper during treatment of acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol. 2012;130:935–7.
O’Halloran HS, Berger JR, Lee WB, et al. Acute multifocal placoid pigment epitheliopathy and central nervous system involvement: nine new cases and a review of the literature. Ophthalmology. 2001;108:861–8.
Wilson CA, Choromokos EA, Sheppard R. Acute posterior multifocal placoid pigment epitheliopathy and cerebral vasculitis. Arch Ophthalmol. 1988;107:796.
Van Buskirk EB, Lessell S, Friedman E. Pigment epitheliopathy and erythema nodosum. Arch Ophthalmol. 1972;85:369.
Deutman AF, Oosterhuis JA, BoenTan TN, et al. Acute posterior multifocal placoid pigment epitheliopathy: pigment epitheliopathy or choriocapillaritis. Br J Ophthalmol. 1972;56:863.
Parmeggiani F, Costagliola C, D’Angelo S, et al. Clear cell renal cell carcinoma associated with bilateral atypical acute posterior multifocal placoid pigment epitheliopathy. Oncology. 2004;66:502.
Anderson K, Patel KR, Webb L, et al. Acute posterior multifocal placoid pigment epitheliopathy associated with pulmonary tuberculosis [letter]. Br J Ophthalmol. 1996;80:186.
Di Crecchio L, Parodi MB, Saviano S, et al. Acute posterior multifocal placoid pigment epitheliopathy and ulcerative colitis: a possible association. Acta Ophthalmol Scand. 2001;79:319.
Chiquet C, Lumbroso L, Denis P, et al. Acute posterior multifocal placoid pigment epitheliopathy associated with Wegener’s granulomatosis. Retina. 1999;19:309.
Hsu CT, Harlan JB, Goldberg MF, et al. Acute posterior multifocal placoid pigment epitheliopathy associated with a systemic necrotizing vasculitis. Retina. 2003;23:64.
Matsuo T, Horikoshi T, Nagai C. Acute posterior multifocal placoid pigment epitheliopathy and scleritis in a patient with pANCA-positive systemic vasculitis. Am J Ophthalmol. 2002;133:566.
Azar P, Gohd RS, Waltman D, et al. Acute posterior multifocal placoid pigment epitheliopathy associated with an adenovirus type 5 infection. Am J Ophthalmol. 1975;80:1003.
Thomson SPS, Roxburgh STD. Acute posterior multifocal placoid pigment epitheliopathy associated with adenovirus infection. Eye. 2003;17:542.
Hollsten JE, McClintock M, Samy H, et al. Fulminant chorioretinitis and papillitis secondary to coxsackievirus B presenting as acute posterior multifocal placoid pigment epitheliopathy with positive response to intravenous immunoglobulin. Retina Cases Brief Rep. 2013;7:225–31.
Mathura JR, Jampol LM, Daily MJ. Multifocal choroiditis and acute posterior multifocal placoid pigment epitheliopathy occurring in the same patient. Arch Ophthalmol. 2004;122:1881.
Wolf MD, Folk JC, Panknen CA, et al. HLA-B7 and HLA-DR2 antigens and acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol. 1990;108:698.
Kim RY, Holz FG, Gregor Z, et al. Recurrent acute multifocal placoid pigment epitheliopathy in two cousins. Am J Ophthalmol. 1995;119:660.
Jampol LM, Becker KG. White spot syndromes of the retina: a hypothesis based on the common genetic hypothesis of autoimmune/inflammatory disease. Am J Ophthalmol. 2003;135:376.
Hayreh SS. Segmental nature of the choroidal vasculature. Br J Ophthalmol. 1975;59:631.
El-Markaby HS, Mohammed TH, El-Raggal TMJR. Acute posterior multifocal placoid pigment epitheliopathy: role of TNF blocker in severe cases. Retina. 2012;32:2102–7.
Mavrakanas N, Mendrinos E, Tabatabay C, et al. Intravitreal ranibizumab for choroidal neovascularization secondary to acute multifocal posterior placoid pigment epitheliopathy. Acta Ophthalmol. 2010;88:e54–5.
Parodi MB, Iacono P, Verbraak FD, et al. Antivascular endothelial growth factors for inflammatory chorioretinal disorders. In: Anti-VEGF, vol. 46. Basel: Karger Publishers; 2010. p. 84–95.
Schatz H, Maumenee AE, Patz A. Geographic helicoid peripapillary choroidopathy: clinical presentation and fluorescein angiographic findings. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:747.
Mansour AM, Jampol LM, Packo KH, Hrisomalos NF. Macular serpiginous choroiditis. Retina. 1988;8:125.
King DG, Grizzard WS, Sever RJ, Espinoza L. Serpiginous choroidopathy associated with elevated factor VIII-von Willebrand factor antigen. Retina. 1990;10:97.
Jampol LM, Orth D, Daily MJ, Rabb MF. Subretinal neovascularization with geographic (serpiginous) choroiditis. Am J Ophthalmol. 1979;88:683.
Gass JDM. Specific choroidal diseases causing disciform macular detachment. In: Gass JDM, editor. Stereoscopic atlas of macular diseases: diagnosis and treatment. 3rd ed. St. Louis: CV Mosby; 1987. p. 136.
Green WR. The uveal tract. In: Spencer WH, editor. Ophthalmic pathology: an atlas and textbook. 3rd ed. Philadelphia: WB Saunders; 1986. p. 1994.
Schlaegel TF Jr. Metastatic nonsuppurative uveitis. In: Schlaegel Jr TF, editor. Essentials of uveitis, vol. 77. Boston: Little Brown; 1969.
Schatz H, McDonald HR. Geographic helicoid peripapillary choroidopathy (serpiginous choroiditis). In: Ryan SJ, Schachat AP, Murphy RB, Patz A, editors. Retina. St. Louis: CV Mosby; 1989. p. 705.
Richardson RR, Cooper IS, Smith JL. Serpiginous choroiditis and unilateral extrapyramidal dystonia. Ann Ophthalmol. 1981;13:15.
Hardy RA, Schatz H. Macular geographic helicoid choroidopathy. Arch Ophthalmol. 1987;105:1237.
Sveinsson K. Helicoidal peripapillary chorioretinal degeneration. Acta Ophthalmol. 1979;57:69.
Weiss H, Annesley WH Jr, Shields JA, et al. The clinical course of serpiginous choroidopathy. Am J Ophthalmol. 1979;87:133.
Blumenkranz MS, Gass JDM, Clarkson JG. Atypical serpiginous choroiditis. Arch Ophthalmol. 1982;100:1773.
Jampol LM. The retina: inflammatory diseases. In: Miller S, editor. Clinical ophthalmology. Bristol: Wright; 1987. p. 186.
Laatikainen L, Erkkila H. A follow-up study on serpiginous choroiditis. Acta Ophthalmol. 1981;59:707.
Laatikainen L, Erkkila H. Serpiginous choroiditis. Br J Ophthalmol. 1974;58:777.
Wu JS, Lewis H, Fine SL, et al. Clinicopathologic findings in a patient with serpiginous choroiditis and treated choroidal neovascularization. Retina. 1989;9:292.
Baarsma GS, Deutman AF. Serpiginous (geographic) choroiditis. Doc Ophthalmol. 1976;40:269.
Chisholm IH, Gass JDM, Hutton WL. The late stage of serpiginous (geographic) choroiditis. Am J Ophthalmol. 1976;82:343.
Fujisawa C, Fujiwara H, Hasegawa E, et al. The cases of serpiginous choroiditis [Japanese, English abstract]. Nippon Ganka Gakkai Zasshi. 1978;82:135.
Deutman AF. Choriocapillaris filling patterns in health and disease. Trans Ophthalmol Soc UK. 1968;100:553.
Fitzgerald PJ, Robertson DM. Acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol. 1973;89:373.
Alvi NP, Fishman GA. Granulomatous uveitis presenting with acute posterior multifocal placoid pigment epitheliopathy. Doc Ophthalmol. 1995;89:347.
Dick DJ, Newman PK, Richardson J, et al. Acute posterior multifocal placoid pigment epitheliopathy and sarcoidosis. Br J Ophthalmol. 1988;72:74.
Ciulla TA, Gragoudas ES. Serpiginous choroiditis. Int Ophthalmol Clin. 1996;36:135.
Giovanni A, Ripa E, Scassellati-Sforzolini B, et al. Indocyanine green angiography in serpiginous choroidopathy. Eur J Ophthalmol. 1996;6:299.
Arantes TE, Matos K, Garcia CR, et al. Fundus autofluorescence and spectral domain optical coherence tomography in recurrent serpiginous choroiditis: case report. Ocular Immunol Inflamm. 2011;19:39–41.
Gallagher MJ, Yilmaz T, Cervantes-Castañeda RA, et al. The characteristic features of optical coherence tomography in posterior uveitis. Br J Ophthamol. 2007;91:1680–5.
Piccolino FC, Grosso A, E S, et al. Fundus autofluorescence in serpiginous choroiditis. Graefes Arch Clin Exp Ophthalmol. 2009;247:179–85.
Punjabi OS, Rich R, Davis JL, et al. Imaging serpiginous choroidopathy with spectral domain optical coherence tomography. Ophthalmic Surg Lasers Imaging. 2008;39:S95–8.
van Velthoven ME, Ongkosuwito JV, Verbraak FD, et al. Combined en-face optical coherence tomography and confocal ophthalmoscopy findings in active multifocal and serpiginous chorioretinitis. A J Ophthalmol. 2006;141:972–5.
Ahn SJ, Park SH, BRJOi L, et al. Multimodal imaging including optical coherence tomography angiography in serpiginous choroiditis. Ocular Immunol Inflamm. 2017;25:287–91.
Desai R, Nesper P, Goldstein DA, et al. OCT angiography imaging in serpiginous choroidopathy. Ophthalmol Retina. 2018;2:351–9.
El Ameen A, Herbort CP Jr. Serpiginous choroiditis imaged by optical coherence tomography angiography. Retina Cases Brief Rep. 2018;12:279–85.
Montorio D, Giuffrè C, Miserocchi E, et al. Swept-source optical coherence tomography angiography in serpiginous choroiditis. Br J Ophthalmol. 2018;102:991–5.
Pakzad-Vaezi K, Khaksari K, Chu Z, et al. Swept-source OCT angiography of serpiginous choroiditis. Ophthalmol Retina. 2018;2:712–9.
Carreño E, Portero A, Herreras J, et al. Assessment of fundus autofluorescence in serpiginous and serpiginous-like choroidopathy. Eye. 2012;26:1232.
Masi RJ, O’Connor R, Kimura SJ. Anterior uveitis in geographic or serpiginous choroiditis. Am J Ophthalmol. 1978;86:228.
Nussenblatt RB, Whitcup SM, Palestine AG. Serpiginous choroidopathy. In: Uveitis: fundamentals and clinical practice. 2nd ed. St. Louis: CV Mosby; 1996. p. 364–70.
Laatikainen L, Erkkila H. Subretinal and disc neovascularization in serpiginous choroiditis. Br J Ophthalmol. 1982;66:326.
Wojno T, Meredith TA. Unusual findings in serpiginous choroiditis. Am J Ophthalmol. 1982;94:650.
Erkkila H, Laatikainen L, Jokinen E. Immunological studies on serpiginous choroiditis. Graefes Arch Clin Exp Ophthalmol. 1982;219:131.
Friberg TR. Serpiginous choroiditis with branch vein occlusion and bilateral periphlebitis. Arch Ophthalmol. 1988;106:585.
Huuskonen MS, Tilikainen A, Alanko K. HLA-B18 antigens and protection from pulmonary fibrosis in asbestos workers. Br J Dis Chest. 1979;73:253.
Edelston C, Stanford MR, Graham EM. Serpiginous choroiditis: an unusual presentation of ocular sarcoidosis. Br J Ophthalmol. 1994;78:70.
Mulder CJJ, Pena AS, Jansen J, Oosterhuis JA. Celiac disease and geographic (serpiginous) choroidopathy with occurrence of thrombocytopenic purpura. Arch Intern Med. 1983;143:842.
Broekhuyse RM, Van Herck M, Pinckers AJ, et al. Immune responsiveness to retinal S-antigen and opsin in serpiginous choroiditis and other retinal diseases. Doc Ophthalmol. 1988;69:83.
Gass JDM. Serpiginous choroiditis. In: Gass JDM, editor. Stereoscopic atlas of macular diseases: diagnosis and treatment. 4th ed. St. Louis: Mosby-Year Book; 1997. p. 158–65.
Akpek EK, Chan CC, Shen D, et al. Lack of herpes virus DNA in choroidal tissues of a patient with Serpiginous choroiditis. Ophthalmology. 2004;111:2071.
Nazari Khanamiri H, Rao NA. Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis. Surv Ophthalmol. 2013;58(3):203–32.
Vasconcelos-Santos DV, Rao PK, Davies JB, et al. Clinical features of tuberculous serpiginous like choroiditis in contrast to classic serpiginous choroiditis. Arch Ophthalmol. 2010;128(7):853–8.
Rifkin LM, Munk MR, Baddar D, et al. A new OCT finding in tuberculous serpiginous-like choroidopathy. Ocul Immunol Inflamm. 2015;23(1):53–8.
Wang H, Tan SZ, Aslam T, et al. Multimodal evaluation of presumed tuberculous serpiginous-like choroiditis. Ocul Immunol Inflamm. 2018;00(00):1–5.
Mandadi SKR, Agarwal A, Aggarwal K, et al. Novel findings on optical coherence tomography angiography in patients with tubercular serpiginous-like choroiditis. Retina. 2017;37:1647–59.
Yee HY, Keane PA, Ho SL, et al. Optical coherence tomography angiography of choroidal neovascularization associated with tuberculous serpiginous-like choroiditis. Ocul Immunol Inflamm. 2016;24(6):699–701.
Aggarwal K, Agarwal A, Sharma A, et al. Detection of type 1 choroidal neovascular membranes using optical coherence tomography angiography in tubercular posterior uveitis. Retina. 2018;0:1–12.
Agarwal A, Invernizzi A, Singh RB, et al. An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management. J Ophthalmic Inflamm Infect. 2018;8:13.
Neetens A, Burvenich H. Presumed inflammatory maculopathies. Trans Ophthalmol Soc UK. 1978;98:160.
Pham-Duy T, Miszalok V. Choroiditis geographica. Klin Monatsbl Augenheilkd. 1983;183:278.
Araujo AA, Wells AP, Dick AD, et al. Early treatment with cyclosporine in serpiginous choroidopathy maintains remission and good visual outcome. Br J Ophthalmol. 2000;84:979.
Hooper PL, Kaplan HJ. Triple agent immunosuppression in serpiginous choroidopathy. Ophthalmology. 1990;97(Suppl):109.
Nussenblatt RB. Discussion of Hooper PL, Kaplan HJ: triple agent immunosuppression in serpiginous choroiditis. Ophthalmology. 1991;98:951.
Akpek EK, Jabs DA, Tesseler HH, et al. Successful treatment of serpiginous choroiditis with alkylating agents. Ophthalmology. 2002;109:1506.
Secchi AG, Tognon S, Maselli C. Cyclosporine-A in the treatment of serpiginous choroiditis. Int Ophthalmol. 1990;14:395.
Leznoff A, Shea M, Binkley KE, et al. Cyclosporine in the treatment of nonmicrobial inflammatory ophthalmic disease. Can J Ophthalmol. 1992;27:302.
Venkatesh P, Gogia V, Gupta S, et al. Pulse cyclophosphamide therapy in the management of patients with macular serpiginous choroidopathy. Indian J Ophthalmol. 2015;63:318.
Venkatesh P, Tayade A, Gogia V, et al. Short-term intensive immunosuppression: a randomized, three-arm study of intravenous pulse methylprednisolone and cyclophosphamide in macular serpiginous choroiditis. Ocular Immunol Inflamm. 2018;26:469–76.
Ebrahimiadib N, Modjtahedi BS, Davoudi S, et al. Treatment of serpiginous choroiditis with chlorambucil: a report of 17 patients. Ocular Immunol Inflamm. 2018;26:228–38.
Sobaci G, Bayraktar Z, Bayer A. Interferon alpha-2a treatment for serpiginous choroiditis. Ocular Immunol Inflamm. 2005;13:59.
Miserocchi E, Berchicci L, Iuliano L, et al. Dexamethasone intravitreal implant in serpiginous choroiditis. B J Ophthalmol. 2017;101:327–32.
Julián K, Terrada C, Fardeau C, et al. Intravitreal bevacizumab as first local treatment for uveitis related choroidal neovascularization: long term results. Acta Ophthalmol. 2011;89:179–84.
Rouvas A, Petrou P, Douvali M, et al. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Retina. 2011;31:871–9.
Song M, Roh YJE. Intravitreal ranibizumab for choroidal neovascularisation in serpiginous choroiditis. Eye (Lond). 2009;23:1873.
Navajas EV, Costa RA, Farah ME, et al. Indocyanine green-mediated photothrombosis combined with intravitreal triamcinolone for the treatment of choroidal neovascularization in serpiginous choroiditis. Eye. 2003;17:563.
Lim JI, Flaxel CJ, LaBree LJA-AOMS. Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease. Ann Acad Med Singap. 2006;35:198.
Park SP, Ko DA, Chung H, et al. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in serpiginous choroiditis. Ophthalmic Surg Laser Imaging. 2006;37:425–8.
Duke-Elder S, Perkins E. Inflammations of the uveal tract: uveitis. In: Duke-Elder S, editor. System of ophthalmology. Diseases of the uveal tract. St. Louis: CV Mosby; 1966. p. 246.
Jones EB, Jampol LM, Yanuzzi LA, et al. Relentless placoid chorioretinitis: a new entity or an unusual variant of serpiginous chorioretinitis? Arch Ophthalmol. 2000;118:931.
Gupta V, Agarwal A, Gupta A, et al. Clinical characteristics of serpiginous choroidopathy in North India. Am J Ophthalmol. 2002;134:47.
Bouchenaki N, Cimino L, Auer C, et al. Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography. Klin Monatsbl Augenheilkd. 2002;219:243.
Mirza RG, Jampol LM. Relentless placoid chorioretinitis. Int Ophthalmol Clin. 2012;52(4):237–42.
García-Sáenz MC, Gili Manzanaro P, Bañuelos J, et al. Indocyanine green angiography in chorioretinal inflammatory diseases. Arch Soc Esp Oftalmol. 2003;78:675.
Giovannini A, Mariotti C, Ripa E, et al. Indocyanine green angiography findings in serpiginous choroidopathy. Br J Ophthalmol. 1996;80:536.
Salati C, Pantelis V, Lafaut BA, et al. A 8 months indocyanine green angiographic follow-up of a patient with serpiginous choroidopathy. Bull Soc Belge Ophtalmol. 1997;265:29.
Squirrell DM, Bhola RM, Talbot JF. Indocyanine green angiographic findings in serpiginous choroidopathy: evidence of a widespread choriocapillaris defect of the peripapillary area and posterior pole. Eye. 2001;15:336.
Vabres G. Study of an atypical unilateral choroidopathy of the posterior pole with centrifugal serpiginous development (clinical, angiofluorographic and functional aspects). Ann Ocul (Paris). 1972;205:927.
Amer R, Florescu TJC. Optical coherence tomography in relentless placoid chorioretinitis. Clin Exp Ophthalmol. 2008;36:388–90.
Veronese C, Marcheggiani EB, Tassi F, et al. Early autofluorescence findings of relentless placoid chorioretinitis. Retina. 2014;34:625–7.
Dolz-Marco R, Rodríguez-Ratín Á, Hernández-Martínez P, et al. Macular retinal and choroidal thickness in unilateral relentless placoid chorioretinitis analyzed by swept-source optical coherence tomography. J Ophthalmic Inflamm Infect. 2014;4:24.
Hwang ES, Bell JE, Quigley EP, et al. Stroke due to cerebral vasculitis in a patient with relentless placoid chorioretinitis. Ocular Immunol Inflamm. 2018;26:921–3.
Yeh S, Lew JC, Wong WT, et al. Relentless placoid chorioretinitis associated with central nervous system lesions treated with mycophenolate mofetil. Arch Ophthalmol. 2009;127:341–3.
Obradović L, Jovanović S, Petrović N, et al. Relentless placoid chorioretinitis–a case report. Srp Arh Celok Lek. 2016;144:527–30.
Roth DB, Ballintine S, Mantopoulos D, et al. Relentless placoid chorioretinitis: successful long-term treatment with intravitreal triamcinolone. Retinal Cases & Brief Reports: Spring. 13(2):150–153.
Golchet PR, Jampol LM, Wilson D, et al. Persistent placoid maculopathy: a new clinical entity. Ophthalmology. 2007;114:1530–40.
Gendy MG, Fawzi AA, Wendel RT, et al. Multimodal imaging in persistent placoid maculopathy. JAMA Ophthalmol. 2014;132:38–49.
Kovach JL. Persistent placoid maculopathy imaged with spectral domain OCT and autofluorescence. Ophthalmic Surg Lasers Imaging Retina. 2010;41:S101–3.
Nika M, Kalyani PS, Jayasundera KT, et al. Pathogenesis of persistent placoid maculopathy: a multimodal imaging analysis. Retina. 2015;35:1531–9.
Sassalos TM, Saraf SS, Ober MD, et al. Chorioretinal perfusion in persistent Placoid maculopathy. Ophthalmic Surg Lasers Imaging Retina. 2017;48:1026–31.
Kolomeyer AM, Brucker AJ. Persistent placoid maculopathy: a systematic review. Retina. 2018;38:1881–95.
Puche N, Hera R, Terrada C, et al. Persistent placoid maculopathy imaged by optical coherence tomography angiography. Retina Cases Brief Rep. 2016;10:297–301.
Eadie JA, Gottlieb JL. Successful treatment of choroidal neovascularization secondary to persistent placoid maculopathy with intravitreal bevacizumab. Retina Cases Brief Rep. 2014;8:37–40.
Lenassi E, Kojovic M, Mekjavic PJ, et al. Persistent placoid maculopathy complicated by cerebral vasculitis. J Neuroophthalmol. 2017;37:273–5.
Khairallah M, Yahia SBJO. Persistent placoid maculopathy. Ophthalmology. 2008;115:220–1.
Parodi MB, Iacono P, FJOi B, et al. Juxtafoveal choroidal neovascularization secondary to persistent placoid maculopathy treated with intravitreal bevacizumab. Ocular Immunol Inflamm. 2010;18:399–401.
Waisbren EC, Ho J, Smithen LM, et al. Using ranibizumab to successfully treat choroidal neovascularization in a patient with persistent placoid maculopathy. Retinal Cases Brief Rep. 2010;4:211–5.
Acknowledgments
Strutha C. Rouse II, MD, and Charles J Bock Jr., MD, assisted with the earlier versions of the chapter on SPC.
Evica Simjanoski, CRA, and the retina photographers at Northwestern Medicine contributed to the imaging in this chapter.
The present work was supported in part by an unrestricted grant from Research to Prevent Blindness, Inc., New York City, and a grant from Kevin Hitzeman and Mary Dempsey.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Schaab, T.J., Mirza, R.G., Jampol, L.M. (2020). Placoid Retinopathies: Acute Posterior Multifocal Placoid Pigment Epitheliopathy, Serpiginous Choroiditis, Relentless Placoid Chorioretinitis, and Persistent Placoid Maculopathy. In: Albert, D., Miller, J., Azar, D., Young, L.H. (eds) Albert and Jakobiec's Principles and Practice of Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-319-90495-5_6-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-90495-5_6-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90495-5
Online ISBN: 978-3-319-90495-5
eBook Packages: Springer Reference MedicineReference Module Medicine